We have long participated in congresses, conferences,
round table discussions, etc., whose scientific
features are invariably a mere pretext for the sector’s
economic operators, an occasion to organise marketingbased
advertising operations.
To be frank the sight of professionals wandering about with
paper bags packed with products and little gifts was rather
depressing and even disqualifying.
On 28-29-30 July 2005 there was nothing of all this at the
IATMO Conference (International Academy of Tumour
Marker Oncology) held in Varese: focus only centred on
purely scientific issues.
The speakers, ever present in every session, took it in turn
to intervene with targeted questions, generating information
exchange between equally skilled interlocutors who came
from all parts of the world, as you will read in the following
pages.
The disease’s form and evolution were thoroughly analysed.
Research and the new treatments introduced give rise to
many hopes, but we shall exhaustively develop the point
very soon.
Both justified and unjustified absentees missed a good
chance - the opportunity to participate in one of those rare
meetings where the medical profession plays its qualified
and qualifying role while at the same time it regains ethics,
which have been disregarded for far too long.
Genina Iacobone
Direttore di Leadership Medica
